| |
Project
Title |
Investigator/s |
Budget
(Rs. In Lakhs) |
Date
of Sanction |
Duration
- years |
| 1. |
Cytomodulins
in oral cancer therapy. |
Dr.
D. Karunagaran
IIT, Chennai. |
43.60 |
02.02.2009 |
3 |
| 2. |
Loss
of heterozygosity on specific chromosomal arms
and influence of single nucleotide polymorphisms
in XRCC1and XPD genes in oral and esophageal
cancers induced by raw betel-nut in Meghalaya. |
Dr.
Anupam Chatterjee
NEHU, Shillong. |
18.63 |
29.06.2009 |
3 |
| 3. |
Epigenetic
mechanisms in Ovarian Cancer progression. |
Dr.
Sharmila A Bapat
NCCS, Pune. |
43.99 |
29.06.2009 |
3 |
| 4. |
Comparative
Proteomic and Transcriptomic Analyses of PEPCK
under the influence of Flemingia vestita-derived
Phytoestrogen (Genistein). |
Dr.
Bidyadhar Das
NEHU, Shillong. |
176.40 |
03.08.2009 |
3 |
| 5. |
Neuroendocrine-Immune
interactions in mammary tumorigenesis. |
Dr.
S. Thyagarajan
SRM University, Tamil Nadu. |
40.25 |
19.08.2009 |
3 |
| 6. |
Gene
mutations in patients with chronic pancreatitis
and their role in pathogenesis of malignant
transformation. |
Dr.
Anoop Saraya
AIIMS, New Delhi. |
25.11 |
24.08.2009 |
3 |
| 7. |
Silencing
of MTA1 gene as a strategy to inhibit tumor
angiogenesis and metastasis; Role in breast
cancer therapy. |
Prof.
Bharathi P. Salimath
University of Mysore,
Mysore. |
52.31 |
01.09.2009 |
3 |
| 8. |
Study
on the chemopreventive response of Dolastatin,
a mollusc linear peptide of Indian Ocean origin
in experimental colon cancer. |
Dr.
S. N. Sanyal
Panjab University, Chandigarh |
54.25 |
01.09.2009 |
3 |
| 9. |
Hypoxia
and p53-HIC1 axis in stemness of glial tumors
and cell lines. |
Dr.
Parthaprasad Chattopadhyay
AIIMS, New Delhi |
50.51 |
01.09.2009 |
3 |
| 10. |
Coordinated
role of SMAR1 and p53 in tumorigenesis and
apoptosis. |
Dr.
Samit Chattopadhyay
NCCS, Pune. |
30.00 |
01.09.2009 |
3 |
| 11. |
To study
frequency and load of Human Papilloma Virus
(HPV) in benign, pre-malignant (dysplastic)
and malignant esophageal squamous epithelium
by immunohistochemistry and real time PCR. |
Dr.
Kim Vaiphei
PGIMER, Chandigarh. |
15.52 |
15.09.2009 |
2 |
| 12. |
Functional
genomic delineation of convolutions in Wnt
signaling pathway for gastric cancer diagnostics. |
Dr.
G. Kumaresan
Madurai Kamaraj University, Madurai. |
27.71 |
17.09.2009 |
3 |
| 13. |
Development
of folate receptor - mediated system for targeted
delivery of curcumin in cancer cells. |
Dr.
B. C. Das
ICPO, Noida. |
58.02 |
30.12.2009 |
3 |
| 14. |
Exploring
the potential of TF antigen binding property
of lectin from Sclerotium rolfsii for
anticancer effect. |
Dr.
Shashikala R. Inamdar
Karnatak University,
Dharwad. |
32.74 |
16.02.2010 |
3 |
| 15. |
Identification
of biomarkers for thyroid malignancies in FNACs. |
Dr.
K. Sujathan
RCC, Thiruvananthapuram. |
29.56 |
01.03.2010 |
2 |
| 16. |
Immunogenetic
profile of nasopharyngeal cancer in a high-prevalence
region of Northeast India. |
Dr.
Sunita Saxena
Safdarjang Hospital, New Delhi. |
53.60 |
03.03.2010 |
3 |
| 17. |
Assessment
of therapeutic response of radiolabeled anti
CD20 antibodies 131Iodine Rituximab & 90Yttrium
Rituximab in diffuse large B cell non-Hodgkin's
lymphoma. |
Prof.
Arun Malhotra
AIIMS, New Delhi. |
65.99 |
17.03.2010 |
3 |
| 18. |
Internal
Ribosome Entry Site (IRES) mediated expression
of endogenously produced carboxy-terminal domain
of Connexin 43 (CT-Cx43): Status of expression
in the breast cancer. |
Dr.
Mahboob Ul Hussain
The University of Kashmir,
J&K. |
27.30 |
22.03.2010 |
3 |
| 19. |
Evaluation
of the potential of two monoclonal antibodies
for treatment of androgen-independent prostatic
carcinomas. |
Prof.
G. P. Talwar
TRF, New Delhi. |
62.31 |
25.03.2010 |
3 |
| 20. |
Role
of small molecule inhibitor(s) as targeted
therapy in pancreatic and prostate cancers
using in vitro and in vivo models. |
Dr.
Surajit Sinha
IACS, Kolkata. |
39.56 |
29.03.2010 |
3 |
| 21. |
Development
of a DNA MGBL as a Radioprotector: Molecular
events in the modulation of Ionization radiation
induced genomic instability in vitro and in
vivo. |
Dr.
Vibha Tandon
University of Delhi, Delhi. |
42.72 |
05.05.2010 |
3 |
| 22. |
Design,
synthesis and identification of phosphodiesterase
4 (PDE4) inhibitors possessing improved safety
profile. |
Dr.
Manojit Pal
ILSc, Hyderabad. |
24.99 |
05.05.2010 |
1 |
| 23. |
Embryonic
zebrafish as a model system to study the expression
and role of breast tumour kinase (brk/ptk6). |
Dr.
Anil Kumar Challa
ILSc, Hyderabad. |
39.92 |
05.05.2010 |
3 |
| 24. |
Evaluate
the mechanism of resveratrol mediated apoptosis
in cigarette smoke induced breast cancer. |
Dr.
Chanakaya Nath Kundu
KIIT University, Bhubaneswar. |
34.52 |
20.05.2010 |
3 |
| 25. |
Isolation,
Characterization of Gliomasphere forming cells
from Glioblastoma Multiforme: Correlation with
Prognostic Factors and Treatment Outcome. |
Dr.
Srinivas G
SCTIMST, Thiruvananthapuram. |
32.84 |
26.07.2010 |
2 |
| 26. |
Proteomic
Profiling of squamous cell carcinoma of Esophagus. |
Dr.
T. S. Keshava Prasad
IOB, Bangalore. |
38.20 |
29.09.2010 |
2 |
| 27. |
Investigating
the role of P21 activated kinase 1 (Pak1) signaling
in pancreatic adenocarcinoma (PDAC). |
Dr.
Rayala Suresh Kumar
IIT, Chennai. |
74.69 |
31.01.2011 |
3 |
| 28. |
Development
of HPV 18 chimaeric vaccine candidate. |
Dr.
Neeta Singh
AIIMS, New Delhi. |
23.85 |
03.02.2011 |
2 |
| 29. |
Expression
of miR-200 family, miR-205 and cell surface
proteins as markers of metastasis in thyroid
tumors using real-time PCR and immunohistochemical
analysis. |
Dr.
Rekha Pai
CMC, Vellore. |
19.74 |
16.03.2011 |
2 |
| 30. |
Molecular
basis of chemopreventive agent carvone: NFҝB
as a potential target in 1,2-dimethyhydrazine-induced
colon carcinogenesis. |
Dr.
N. Nalini
AU, Tamilnadu. |
27.98 |
21.02.2011 |
3 |
| 31. |
Development
of cancer researcher database for India. |
Dr.
Renu Goel
IOB, Bangalore. |
13.58 |
28.02.2011 |
1 |
| 32. |
Study
on the significance of Micro-RNA expression
pattern in oral carcinoma. Phase-II: Validation
of microarray results and assessment of its
prognostic significance. |
Dr.
S. Kannan
RCC, Thiruvananthapuram. |
42.61 |
16.03.2011 |
3 |
| 33. |
A proteomic
investigation to identify candidate biomarkers
for Acute Liver Failure and Acute on Chronic
Liver Failure using high resolution mass spectrometry. |
Dr.
S. K. Sarin
ILBS, New Delhi. |
86.30 |
16.03.2011 |
3 |
| 34. |
Identifying
surface marker signature of oral cancer stem
cells to develop a prognosis marker for oral
squamous cell carcinoma using peptide-based
CSC detection. |
Dr.
Tessy Thomas Maliekal
RGCBT, Thiruvananthapuram. |
72.28 |
18.03.2011 |
3 |
| 35. |
Sequence
dependent molecular action of ZD6474 with paclitaxel
and radiation in progression and treatment
of breast cancer. |
Dr.
Mahitosh Mandal
IIT, Kharagpur. |
31.50 |
28.03.2011 |
3 |
| 36. |
Glioma
serum biomarker discovery through proteomic
approaches. |
Dr.
Kumaravel Somasundaram
IISc, Bangalore. |
83.10 |
28.03.2011 |
3 |
| 37. |
A yeast
based screen for discovery of novel sirtuin
inhibitors as anti-cancer agents. |
Dr.
Devyani Haldar
ILSc, Hyderabad. |
32.52 |
28.03.2011 |
3 |
| 38. |
A chemical
biology approach to discover Allosteric
Modulators of Sirtuins and to understand
their mode of action. |
Dr.
Prabhat Arya
ILSc, Hyderabad. |
29.60 |
28.03.2011 |
3 |
| 39 |
Development
of therapeutic peptides from small proteoglycan
luecine rich repeat family for the inhibition
of tumor angiogenesis. |
Prof.
K. N. Sulochana
VRF, Chennai. |
19.16 |
30.06.2011 |
3 |
| 40. |
Salivary
transcriptome and proteome for the diagnosis
and prognosis of oral cancer |
Dr.
M A Kuriakose
MSCC, Bangalore |
59.51 |
12.9.2011 |
3 |
| 41. |
Designing
of cost effective, quick and easy visualization
method for detection of CML, AML and ALL leukemia
patients using Molecular Beacons. |
Prof.
Daman Saluja
Dr. B. R. Ambedkar Center for
Biomedical Research, Delhi. |
42.19 |
28.03.2011 |
3 |
| 42. |
A
comprehensive understanding of the Nasopharyngeal
Carcinoma (NPC) in the North-Eastern Region
of India |
Dr.
Ashok Kumar Das
Dr. Bhubaneshwar Borooah Cancer
Institute, Guwahati, (Assam) |
62.53 |
25-03-2011 |
3 |
| 43. |
-- |
Prof.
Sankar Kumar Ghosh Assam University
Silchar
Assam |
177.03 |
-- |
3 |
| 44. |
-- |
Dr.Tathagata
Choudhuri
Institute of Life Sciences, Bhubaneswar |
332.05 |
-- |
3 |
| 45. |
|
Dr.
Ravi Kannan
Director Cachar Cancer Hospital & Research
Centre, Meherpur, Silchar |
33.31 |
|
3 |
| 46. |
-- |
Dr.
Narender K. Mehra
AIIMS, New Delhi |
64.23 |
-- |
3 |
| 47. |
|
Civil
Hospital
Azwal, Mizoram |
21.78 |
-- |
3 |
| 48. |
-- |
Dr Debroy
Civil Hospital, Dimapur, Nagaland |
21.78 |
-- |
3 |
| 49. |
-- |
Dr Tsring
Arunachal State Hospital, Naharlagun, Arunachal
Pradesh |
21.78 |
-- |
3 |
| 50. |
-- |
Guwahati
Medical College
Guwahati |
1.65 |
-- |
3 |
| 51. |
|
Regional
Institute of Medical Sciences, Imphal |
21.78 |
|
3 |
| 52. |
-- |
DBT
Co-ordination Cell
ILS, Bhubaneshwar |
63.20 |
-- |
3 |